lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

A Role for CD300f Gene in Resistance to Cerebral Malaria Revealed in B6.WLA-Berr2 Congenic Mice

48 Pages Posted: 1 Aug 2019

See all articles by Keswani Tarun

Keswani Tarun

University of Lille II - Center for Infection and Immunity of Lille

Roland Jacques

University of Lille II - Center for Infection and Immunity of Lille

Herbert Fabien

University of Lille II - Center for Infection and Immunity of Lille

Delphine Delcroix-Genete

University of Lille II - Center for Infection and Immunity of Lille

Hélène Bauderlique-Le Roy

University of Lille II - Institut Pasteur de Lille

Gaayeb Lobna

University of Lille II - Center for Infection and Immunity of Lille

Pierre-Andre Cazenave

University of Lille II - Center for Infection and Immunity of Lille; Sorbonne University

Sylviane Pied

University of Lille II - Institut Pasteur de Lille; University of Lille II - Center for Infection and Immunity of Lille

More...

Abstract

Background: Malaria is a complex pathological disease. Genetic mapping and genome-wide studies provide evidence for the association of several genetic polymorphisms with malaria severity degrees. However, the genetic factors that predispose to CM remain poorly understood. We previously studied the genetic determinism of experimental CM (ECM) using the mouse malaria parasite P. berghei ANKA (PbA). We described two loci, Berr1WLA and Berr1WLA, associated with resistance to ECM (CMR) in WLA/Pas mice. In this study, we analyzed the consequences induced by PbA infection in these new congenic mouse strains.

Methods: We derived two congenic strains on the C57BL/6JR background for Berr1WLA and Berr1WLA alleles, which were partially and highly CMR, respectively compared to C57BL/6JR CMS mice. The mechanisms associated with the CMR phenotype were studied by combining genotype, transcriptomic and immune response analyses.

Findings: Upon P. berghei ANKA infection, mice bearing the Berr1WLA allele showed reduced parasite load, blood brain barrier disruption and diminished CXCR3+ T cell infiltration in the brain along with altered astrocyte, microglia, and monocyte response and decreased pro-inflammatory factors production. We have identified the CD300f as a potential candidate gene associated with CM resistance. We found that brain monocytes and microglial cells from B6.W-Berr2 compared to B6 mice highly expressed the CD300f receptors upon PbA infection.

Interpretation: This report underlines the value of using congenic mouse strains to identify novel genetic factors in the etiology of CM and provides a unique model for studying the immunopathological processes associated to severe malaria.

Fundaing Statement: This work was supported by ARCir “Dynamique” Région Nord-Pas de Calais and the LabEx PARAFRAP: ANR-11-LABX-0024. TK is a recipient of PRESTIGE (Sanction No.2014-1- 0043: Marie Curie Actions / FP7 / PCOFUND-GA-2013-609102) and Région Haut-de-France (CNRS - Sanction No.147894) Post-doctoral Fellowship and Fondation des Treilles (Young Rresearcher Prize 2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Declaration of Interests: The authors declare no competing interests.

Ethics Approval Statement: All animal work was conducted in strict accordance with the Directive 2010/63/EU of the European Parliament and Council ‘On the protection of animals used for scientific purposes’. All protocols were approved by the Ethical Committee of Institute Pasteur of Lille and the French Ministry of Agriculture (permit number A 75-15-28) and performed in compliance with the NIH Animal Welfare Assurance #A5476-01 issued on 02/07/2007. All efforts were taken to minimize animal suffering.

Keywords: Cerebral malaria, Genetics, P. berghei ANKA, neuroinflammation, neuroprotection, congenic mouse, CD300, Immunophenotyping

Suggested Citation

Tarun, Keswani and Jacques, Roland and Fabien, Herbert and Delcroix-Genete, Delphine and Bauderlique-Le Roy, Hélène and Lobna, Gaayeb and Cazenave, Pierre-Andre and Pied, Sylviane, A Role for CD300f Gene in Resistance to Cerebral Malaria Revealed in B6.WLA-Berr2 Congenic Mice (January 4, 2019). Available at SSRN: https://ssrn.com/abstract=3310606 or http://dx.doi.org/10.2139/ssrn.3310606

Keswani Tarun

University of Lille II - Center for Infection and Immunity of Lille

Lille Cedex, 59020
France

Roland Jacques

University of Lille II - Center for Infection and Immunity of Lille

Lille Cedex, 59020
France

Herbert Fabien

University of Lille II - Center for Infection and Immunity of Lille

Lille Cedex, 59020
France

Delphine Delcroix-Genete

University of Lille II - Center for Infection and Immunity of Lille

Lille Cedex, 59020
France

Hélène Bauderlique-Le Roy

University of Lille II - Institut Pasteur de Lille

Lille Cedex
France

Gaayeb Lobna

University of Lille II - Center for Infection and Immunity of Lille

Lille Cedex, 59020
France

Pierre-Andre Cazenave

University of Lille II - Center for Infection and Immunity of Lille

Lille Cedex, 59020
France

Sorbonne University

UFR 927, 4 Place Jussieu
Paris, PA F-75252
France

Sylviane Pied (Contact Author)

University of Lille II - Institut Pasteur de Lille ( email )

Lille Cedex
France

University of Lille II - Center for Infection and Immunity of Lille ( email )

Lille Cedex, 59020
France